化合物简介
Salinosporamide A is a potent proteasome inhibitor being studied as a potential anticancer agent. It entered phase I human clinical trials for the treatment of multiple myeloma, only three years after its discovery in 2003. This marine natural product is produced by the obligate marine bacteria Salinispora tropica and Salinispora arenicola, which are found in ocean sediment. Salinosporamide A belongs to a family of compounds, known collectively as salinosporamides, which possess a densely functionalized γ-lactam-β-lactone bicyclic core.
基本信息
中文名称
NPI 0052
英文名称
salinosporamide A
中文别名
英文别名
MARIZOMIB、(1S,2R,5R)-2-(2-chloroethyl)-5-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-1-methyl-7-oxa-4-azabicyclo[3.2.0]heptane-3,6-dione、NPI-0052、UNII-703P9YDP7F
CAS号
437742-34-2
分子式
C15H20ClNO4
分子量
313.777
精确质量
313.108
PSA
79.12
LOGP
1.4087
编号系统
UNII
703P9YDP7F
物化性质
储存条件
4ºC
合成路线
上游原料
共找到72个上游原料 >